This is a preview of subscription content, log in via an institution to check access.
Reference
Farahnik B, et al. Use of an oral phosphodiesterase-4 inhibitor (Apremilast) for the treatment of chronic, severe atopic dermatitis: A case report. Dermatology Online Journal 23: 9, No. 5, 15 May 2017. Available from: URL: http://escholarship.org/uc/item/3588p0hn - USA
Rights and permissions
About this article
Cite this article
Apremilast/ciclosporin. Reactions Weekly 1661, 49 (2017). https://doi.org/10.1007/s40278-017-33337-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-33337-7